Amid upheaval for leading industry players Sandoz, Teva and Viatris, Amneal sees room to grow both in its home market and internationally, according to co-CEO Chirag Patel.
With Teva under new management, Sandoz preparing to be spun off from parent company Novartis and Viatris increasingly focusing on areas outside of the off-patent sector, Amneal co-CEO Chirag Patel sees such industry upheaval as an opportunity for the US generics and biosimilars player.
Speaking at the J.P. Morgan Healthcare Conference in San Francisco, Patel observed that “the changes that are happening in the...
Mounjaro, Eliquis, and Darzalex buck the Q1 trend to make gains
Steffen Wagner has taken over as Stada’s head of Germany, adding to his existing responsibilities in Europe, after Eelco Ockers stepped down from the role. Ockers’ departure comes as German generics giant Stada restructures its business to bring its branded and consumer health interests into closer alignment as part of a more streamlined model.
Video provides a powerful way to help you prove your point. When you click Online Video, you can paste in the embed code for the video you want to add. You can also type a keyword to search online for the video that best fits your document.
